Oxford Biomedica plc (OXB.L)
GBp 425.5
(1.07%)
GBp 425.5
(1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.4 Million | -12.61 Million | 25.45 Million | 3.11 Million | -3.5 Million | 12.86 Million |
| Net Income | -157.49 Million | -45.97 Million | 19.88 Million | -5.69 Million | -14.46 Million | 13.91 Million |
| Depreciation & Amortization | 29.23 Million | 26.35 Million | 12.45 Million | 9.83 Million | 5.78 Million | 4.35 Million |
| Deferred income taxes | - | - | 994 Thousand | 7 Million | 3.13 Million | - |
| Stock-based compensation | 3.51 Million | 6.47 Million | 3.98 Million | 3.28 Million | 2.24 Million | 1.24 Million |
| Change in working capital | 17.45 Million | 4.91 Million | -12.9 Million | -12.15 Million | -2.08 Million | -2.29 Million |
| Other non-cash items | 130.44 Million | -4.38 Million | 1.05 Million | 831 Thousand | 1.88 Million | -4.35 Million |
| Investing Cash Flow | -1.44 Million | -56.46 Million | -9.46 Million | -10.8 Million | -19.39 Million | -10.09 Million |
| Investments in PPE | -9.83 Million | -16.29 Million | -9.46 Million | -13.35 Million | -25.77 Million | -10.14 Million |
| Acquisitions | 8.39 Million | -99.2 Million | - | - | 2000.00 | - |
| Investment purchases | - | - | - | - | -2000.00 | - |
| Sales/Maturities of investments | - | - | - | 2.52 Million | 6.27 Million | - |
| Other Investing Activities | 12.63 Million | 59.04 Million | - | 34 Thousand | 106 Thousand | 52 Thousand |
| Financing Cash Flow | -8.56 Million | 98.62 Million | 46.2 Million | 38.18 Million | 6.9 Million | 15.14 Million |
| Debt repayment | -3.11 Million | -31.42 Million | -4.52 Million | -292 Thousand | -43.58 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 651 Thousand | 80.15 Million | 51.6 Million | 41.06 Million | 55.47 Million | 21.18 Million |
| Other Financing Activities | -9.58 Million | 49.89 Million | -873 Thousand | -2.58 Million | -4.98 Million | -6.04 Million |
| Accounts receivables | 28.79 Million | -17.87 Million | 6.89 Million | -25.89 Million | -4.58 Million | -14.55 Million |
| Accounts payables | -18.12 Million | 16.95 Million | -657 Thousand | 5.41 Million | 2.86 Million | 2.73 Million |
| Inventory | -247 Thousand | 668 Thousand | -2.6 Million | -4.33 Million | 1.67 Million | -919 Thousand |
| Other working capital | 7.03 Million | 5.16 Million | -16.53 Million | 12.65 Million | -2.04 Million | 10.45 Million |
| Cash at beginning of period | 141.28 Million | 108.94 Million | 46.74 Million | 16.24 Million | 32.24 Million | 14.32 Million |
| Cash at end of period | 103.71 Million | 141.28 Million | 108.94 Million | 46.74 Million | 16.24 Million | 32.24 Million |
| Capital Expenditure | -9.83 Million | -16.29 Million | -9.46 Million | -13.35 Million | -25.77 Million | -10.14 Million |
| Effect of forex changes on cash | 845 Thousand | 2.79 Million | - | - | - | - |
| Net cash flow / Change in cash | -37.56 Million | 32.34 Million | 62.2 Million | 30.5 Million | -16 Million | 17.91 Million |
| Free Cash Flow | -38.23 Million | -28.91 Million | 15.99 Million | -10.24 Million | -29.28 Million | 2.72 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.48 Million | -157.49 Million | -109.53 Million | -47.95 Million | -13.67 Million | -45.97 Million |
| Depreciation & Amortization | 11.48 Million | 29.23 Million | 13.87 Million | 14.83 Million | 15.22 Million | 26.35 Million |
| Deferred income taxes | - | - | - | -15.66 Million | -15.34 Million | - |
| Stock-based compensation | 431 Thousand | 3.51 Million | 984 Thousand | 2.53 Million | 4.26 Million | 6.47 Million |
| Change in working capital | -13.93 Million | 17.45 Million | 5.47 Million | 24.91 Million | 24.53 Million | 4.91 Million |
| Other non-cash items | -4.69 Million | 130.44 Million | 66.1 Million | 13.04 Million | -5.51 Million | -4.38 Million |
| Investing Cash Flow | 7.28 Million | -1.44 Million | 1.02 Million | -434 Thousand | 48.25 Million | -56.46 Million |
| Investments in PPE | -4.81 Million | -9.83 Million | -4.97 Million | -4.85 Million | -10.28 Million | -16.29 Million |
| Acquisitions | 9 Million | 8.39 Million | 3.97 Million | 4.42 Million | 59.96 Million | -99.2 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3.09 Million | 12.63 Million | 6 Million | 6.63 Million | -1.42 Million | 59.04 Million |
| Financing Cash Flow | 9.78 Million | -8.56 Million | -5.81 Million | -1.8 Million | -35.13 Million | 98.62 Million |
| Debt repayment | -2.69 Million | -3.11 Million | - | -2.22 Million | -34.64 Million | -31.42 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 16.99 Million | 651 Thousand | 229 Thousand | 422 Thousand | 72 Thousand | 80.15 Million |
| Other Financing Activities | 12.48 Million | -9.58 Million | -5.81 Million | -4.67 Million | 2.2 Million | 49.89 Million |
| Accounts receivables | -13.12 Million | 28.79 Million | 4.8 Million | 23.99 Million | 8.48 Million | -17.87 Million |
| Accounts payables | 2.9 Million | -18.12 Million | -11.58 Million | -6.53 Million | 9.67 Million | 16.95 Million |
| Inventory | -804 Thousand | -247 Thousand | 670 Thousand | -917 Thousand | 1.2 Million | 668 Thousand |
| Other working capital | -6.18 Million | 7.03 Million | -2000.00 | 8.37 Million | 5.16 Million | 5.16 Million |
| Cash at beginning of period | 103.71 Million | 141.28 Million | 129.43 Million | 141.28 Million | 118.51 Million | 108.94 Million |
| Cash at end of period | 81.4 Million | 103.71 Million | 103.71 Million | 129.43 Million | 141.28 Million | 141.28 Million |
| Capital Expenditure | -4.81 Million | -9.83 Million | -4.97 Million | -4.85 Million | -10.28 Million | -16.29 Million |
| Effect of forex changes on cash | -177 Thousand | 845 Thousand | 2.17 Million | -1.33 Million | 164 Thousand | 2.79 Million |
| Net cash flow / Change in cash | -22.3 Million | -37.56 Million | -25.71 Million | -11.85 Million | 22.77 Million | 32.34 Million |
| Free Cash Flow | -44.01 Million | -38.23 Million | -28.08 Million | -13.14 Million | -803 Thousand | -28.91 Million |
0266
AXIL
688128
CNPPF
688565
BORORENEW